Pharmacometabolomic Assessment of Metformin in Non-diabetic, African Americans

Millions of individuals are diagnosed with type 2 diabetes mellitus (T2D), which increases the risk for a plethora of adverse outcomes including cardiovascular events and kidney disease. Metformin is the most widely prescribed medication for the treatment of T2D; however, its mechanism is not fully...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Pharmacol
Egile Nagusiak: Rotroff, Daniel M., Oki, Noffisat O., Liang, Xiaomin, Yee, Sook Wah, Stocker, Sophie L., Corum, Daniel G., Meisner, Michele, Fiehn, Oliver, Motsinger-Reif, Alison A., Giacomini, Kathleen M., Kaddurah-Daouk, Rima
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2016
Gaiak:
Pharmacology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4906013/
https://ncbi.nlm.nih.gov/pubmed/27378919
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2016.00135
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak